CHO-K1-based OATP1B1 Substrate Assessment Service

As a liver-specific transporter, OATP1B1 plays a key role in the uptake of various drugs and endogenous compounds by hepatocytes. In order to assess a compound as a substrate for OATP1B1, a commonly used in vitro model involves using Chinese hamster ovary (CHO) cells expressing the human OATP1B1 transporter. Creative Biolabs utilizes the CHO-K1 cell line to assess the permeability of compounds through OATP1B1.

OATP1B1

OATP1B1 (organic anion-transporting polypeptide 1B1) is a liver-specific transporter protein that is responsible for the uptake of various endogenous and exogenous compounds into hepatocytes. It is known to transport a wide range of substrates, including bile acids, steroid hormones, and a variety of drugs and drug metabolites.

CHO-K1-based OATP1B1 Substrate Assessment Service

Our CHO-K1-based OATP1B1 substrate assessment service is designed to evaluate the substrate specificity of compounds for OATP1B1, a key transporter involved in the uptake of various drugs and endogenous compounds. Using a cell-based assay system, we measure the transport of your compound by OATP1B1 and determine its potential to interact with this transporter. By assessing the substrate potential of your compound for OATP1B1, you can gain valuable insights into its pharmacokinetic properties and potential drug-drug interactions. This information can help guide further development of your compound and optimize its therapeutic potential. Here's the specific information about this service:

Assay Information

Construct Details

Full length, recombined

Cell Type

CHO-K1

Assay Type

Functional

Assay Sub Type

Cell Based

Process of Our Service

1

Generation of OATP1B1-CHO Cells

CHO cells can be transfected with a plasmid containing the gene encoding human OATP1B1 to create stable OATP1B1-CHO cell lines.

2

Uptake Assay

The OATP1B1-CHO cells can be incubated with the test compound at a relevant concentration. Samples can be taken at various time points to measure the intracellular accumulation of compounds. The uptake is measured using radioactively labeled compounds or LC-MS/MS quantitation method.

3

Competitive Inhibition Assay

The substrate potential of the test compound can be further confirmed by performing competitive inhibition studies using known OATP1B1 substrates.

4

Inhibition studies

Transporter inhibitors can be used as positive controls to show the specificity of the uptake by OATP1B1

5

Data Analysis

The uptake data can be analyzed to determine the kinetic parameters (e.g. Km and Vmax) of the test compound for OATP1B1.

Prospect of Our Service

Frequently Asked Question

A1: What is the timeframe for the CHO-K1-based OATP1B1 substrate evaluation service?

Q1: The timeframe for the CHO-K1-based OATP1B1 substrate evaluation service can vary depending on the specific requirements of the study and the availability of resources. Generally, the evaluation service can be completed within 4-6 weeks, depending on the complexity of the study design and the number of samples that need to be processed. It is recommended to contact us for a more accurate estimate of the timeframe for a particular evaluation.

Contact Us

Our experienced team of scientists can customize our assay to meet your specific needs and provide reliable data on the substrate specificity of your compound for OATP1B1. Contact us now to learn more about our CHO-K1-based OATP1B1 substrate assessment service and how we can support your drug development efforts.

For Research Use Only | Not For Clinical Use

Resources
Online Inquiry
Copyright © 2024 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.